CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
CAMP4 Therapeutics focuses on regRNA therapies for genetic diseases. Recent news includes clinical trial updates and strategic collaborations, impacting market positioning.
